Guest guest Posted April 1, 2011 Report Share Posted April 1, 2011 Another CD19 monoclonal has been announced by Glenmark Pharmaceuticals of Switzerland/India called GBR 401. The company plans to move forward with development and clinical trials. This follows XmAb5574 (Xencor Inc) with has been studied by JC Byrd et al for the past year or more. Very early days... ~chris Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.